BHVN Biohaven Ltd.
Healthcare$9.92+0.00%OpenMarket Cap: $1.05B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
10.77
P/S
0.00
EV/EBITDA
-1.54
DCF Value
$-0.55
FCF Yield
-59.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-866.5%
ROA
-138.9%
ROIC
-157.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-130.4M | $-130.5M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-142.7M | $-145.6M | $— | — |
| FY null | $0.00 | -Infinity% | $-745.4M | $-738.8M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-169.4M | $-173.4M | $— | — |
| Q2 null | $0.00 | NaN% | $-211.7M | $-198.1M | $— | — |
| Q1 null | $0.00 | NaN% | $-221.6M | $-221.7M | $— | — |
| Q4 null | $0.00 | NaN% | $-189.9M | $-186.8M | $— | — |
| FY null | $0.00 | NaN% | $-885.1M | $-846.4M | $— | — |
| Q3 null | $0.00 | NaN% | $-178.2M | $-160.3M | $— | — |
| Q2 null | $0.00 | NaN% | $-333.8M | $-319.8M | $— | — |
| Q1 null | $0.00 | NaN% | $-183.2M | $-179.5M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-153.7M | $-144.8M | $-1.81 | — |